ARTICLE | Company News
Biovitrum hematology, endocrine, neurology news
January 26, 2009 8:00 AM UTC
Biovitrum markets products for hemophilia, chemotherapy-induced nausea and vomiting (CINV), chemotherapy-induced oral mucositis and rheumatoid arthritis (RA). Last year, the company discontinued its e...